75% of all Alzheimer’s patients are undiagnosed.

That’s over 41 million patients worldwide. The reason? 11-month wait times and up to $8000 in costs make diagnosis impossible for millions globally. 
This is where AlziDetect comes in. Using facial analysis with AI, our proprietary Gaze Test identifies early signs of Alzheimer’s disease in under five minutes and is free for patients, enabling faster risk detection.

We don’t just stop there. Once identified, at-risk patients can use our progress dashboard and communication tools with medical experts to get early support before it's too late.

With the market growing to over $26 billion by 2032, AlziDetect addresses a massive and urgent global need, and we have already begun working with clinics, hospitals, and patients to validate our approach. 

Our goal is simple: move Alzheimer’s risk detection from months to minutes so patients can act while it still matters.

Founder: Ryan Borui Zhu
Co-founder: Ali-Mansur Valiyev

AlziDetect

Org chart

Teams

Offices